Achaogen, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on the development of innovative antibiotics to combat multidrug-resistant bacterial infections. The company specializes in the discovery and commercialization of novel therapies that address critical unmet medical needs in infectious diseases. Achaogen's research emphasizes the use of advanced technologies and scientific expertise to create effective treatments that enhance patient outcomes and public health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

22 Patents

#58 in South San Francisco, CA

#3,582 in California

#15,021 in US

#28,749 in the World

South San Francisco, CA, United States of America

Achaogen, Inc.

Forward Citations = 125

30 inventors:

James Bradley Aggen (18 out of 51 patents)

Martin Sheringham Linsell (18 out of 82 patents)

Paola Dozzo (18 out of 19 patents)

4. Adam Aaron Goldblum (16 out of 47 patents)

5. Darin James Hildebrandt (12 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Achaogen, Inc.. Retrieved from https://idiyas.com/company/achaogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]